Primary open-angle glaucoma

New England Journal of Medicine

Volumn 360, Issue 11, 2009, Pages 1113-1124

  Kwon, Young H ^a,b   Fingert, John H ^a   Kuehn, Markus H ^a   Alward, Wallace L M ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HEALTH CARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MYOCILIN;

AQUEOUS HUMOR FLOW; CELLULAR STRESS RESPONSE; CLINICAL FEATURE; GENE MUTATION; HUMAN; INTRAOCULAR HYPERTENSION; MAJOR HISTOCOMPATIBILITY COMPLEX; MUTATIONAL ANALYSIS; NONHUMAN; OPEN ANGLE GLAUCOMA; OPTIC NERVE LESION; PREVALENCE; PRIORITY JOURNAL; RETINA GANGLION CELL; REVIEW; RISK FACTOR; TRABECULAR MESHWORK;

EID: 62349090894     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMra0804630     Document Type: Review

References (110)

1. Hayreh SS, Jonas JB. Optic disc morphology after arteritic anterior ischemic optic neuropathy. Ophthalmology 2001; 108:1586-94.
2. Alward WL. Biomedicine: a new angle on ocular development. Science 2003;299: 1527-8.
3. Fingert JH, Héon E, Liebmann JM, et al. Analysis of myocilin mutations in 1703 glaucoma patients from five different populations. Hum Mol Genet 1999;8:899-905.
4. Aldred MA, Baumber L, Hill A, et al. Low prevalence of MYOC mutations in UK primary open-angle glaucoma patients limits the utility of genetic testing. Hum Genet 2004;115:428-31.
5. Graul TA, Kwon YH, Zimmerman MB, et al. A case-control comparison of the clinical characteristics of glaucoma and ocular hypertensive patients with and without the myocilin Gln368Stop mutation. Am J Ophthalmol 2002;134:884-90.
6. Kwon YH, Caprioli J. Primary open angle glaucoma. In: Tasman W, Jaeger EA, eds. Duane's clinical ophthalmology. Philadelphia: J.B. Lippincott, 1999:1-30.
7. Alward WLM. Open angle glaucomas. In: Alward WLM, ed. Glaucoma: the requisites in ophthalmology. St. Louis: Mosby, 2000:128-40.
8. Rudnicka AR, Mt-Isa S, Owen CG, Cook DG, Ashby D. Variations in primary open-angle glaucoma prevalence by age, gender, and race: a Bayesian meta-analysis. Invest Ophthalmol Vis Sci 2006;47:4254-61.
9. Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans: the Baltimore Eye Survey. Arch Ophthalmol 1991;109:1090-5.
10. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. Hypertension, perfusion pressure, and primary open-angle glaucoma: a population-based assessment. Arch Ophthalmol 1995;113:216-21.
11. Idem. Family history and risk of primary open angle glaucoma: the Baltimore Eye Survey. Arch Ophthalmol 1994;112: 69-73.
12. Mitchell P, Hourihan F, Sandbach J, Wang JJ. The relationship between glaucoma and myopia: the Blue Mountains Eye Study. Ophthalmology 1999;106:2010-5.
13. Wong TY, Klein BE, Klein R, Knudtson M, Lee KE. Refractive errors, intraocular pressure, and glaucoma in a white population. Ophthalmology 2003;110:211-7.
14. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:714-20.
15. Clinical epidemiology of glaucoma. In: Allingham RR, Damji KF, Freedman S, Moroi SE, Shafranov G, Shields MB. Shields' textbook of glaucoma. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2005:170-90.
16. Bahrami H. Causal inference in primary open angle glaucoma: specific discussion on intraocular pressure. Ophthalmic Epidemiol 2006;13:283-9.
17. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002;120:1268-79.
18. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701-13.
19. Alward WL. Medical management of glaucoma. N Engl J Med 1998;339:1298-307.
20. Weinreb RN, Khaw PT. Primary openangle glaucoma. Lancet 2004;363:1711-20.
21. Johnson AT, Richards JE, Boehnke M, et al. Clinical phenotype of juvenile-onset primary open-angle glaucoma linked to chromosome lq. Ophthalmology 1996; 103:808-14.
22. Sheffield VC, Stone EM, Alward WL, et al. Genetic linkage of familial open angle glaucoma to chromosome 1q21-q31. Nat Genet 1993;4:47-50.
23. Wiggs JL. Genetic etiologies of glaucoma. Arch Ophthalmol 2007;125:30-7.
24. Ortego J, Escribano J, Coca-Prados M. Cloning and characterization of subtracted cDNAs from a human ciliary body library encoding TIGR, a protein involved in juvenile open angle glaucoma with homology to myosin and olfactomedin. FEES Lett 1997;413:349-53.
25. Polansky JR, Fauss DJ, Chen P, et al. Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response gene product. Ophthalmologica 1997;211:126-39.
26. Kubota R, Noda S, Wang Y, et al. A novel myosin-like protein (myocilin) expressed in the connecting cilium of the photoreceptor: molecular cloning, tissue expression, and chromosomal mapping. Genomics 1997;41:360-9.
27. Stone EM, Fingert JH, Alward WL, et al. Identification of a gene that causes primary open angle glaucoma. Science 1997;275:668-70.
28. Wiggs JL, Allingham RR, Vollrath D, et al. Prevalence of mutations in TIGR/ Myocilin in patients with adult and juvenile primary open-angle glaucoma. Am J Hum Genet 1998;63:1549-52.
29. Stoilova D, Child A, Brice G, et al. Novel TIGR/MYOC mutations in families with juvenile onset primary open angle glaucoma. J Med Genet 1998;35:989-92.
30. Adam MF, Belmouden A, Binisti P, et al. Recurrent mutations in a single exon encoding the evolutionarily conserved ol-factomedin-homology domain of TIGR in familial open-angle glaucoma. Hum Mol Genet 1997;6:2091-7.
31. Fingert JH, Stone EM, Sheffield VC, Alward WL. Myocilin glaucoma. Surv Ophthalmol 2002;47:547-61.
32. Rezaie T, Child A, Hitchings R, et al. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 2002;295:1077-9.
33. Monemi S, Spaeth G, DaSilva A, et al. Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1. Hum Mol Genet 2005;14:725-33.
34. Challa P. Glaucoma genetics. Int Ophthalmol Clin 2008;48(4):73-94.
35. Alward WLM, Fingert JH, Coote MA, et al. Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A). N Engl J Med 1998;338:1022-7.
36. Allingham RR, Wiggs JL, De La Paz MA, et al. Gln368STOP myocilin mutation in families with late-onset primary open-angle glaucoma. Invest Ophthalmol Vis Sci 1998;39:2288-95.
37. FingertJH, Ying L, Swiderski RE, et al. Characterization and comparison of the human and mouse GLC1A glaucoma genes. Genome Res 1998;8:377-84.
38. Nguyen TD, Chen P, Huang WD, Chen H, Johnson D, Polansky JR. Gene structure and properties of TIGR, an olfaeto-medin-related glycoprotein cloned from glucocorticoid-induced trabecular meshwork cells. J Biol Chem 1998;273:6341-50.
39. Lutjen-Drecoll E, May CA, Polansky JR, Johnson DH, Bloemendal H, Nguyen TD. Localization of the stress proteins alpha B-crystallin and trabecular meshwork inducible glucocorticoid response protein in normal and glaucomatous trabecular meshwork. Invest Ophthalmol Vis Sci 1998;39:517-25.
40. Jacobson N, Andrews M, Shepard AR, et al. Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor. Hum Mol Genet 2001;10:117-25.
41. O'Brien TE, Metheney CD, Polansky JR. Immunofluorescence method for quantifying the trabecular meshwork glucocorticoid response (TIGR) protein in trabecular meshwork and Schlemm's canal cells. Curr Eye Res 1999;19:517-24.
42. Wordinger RJ, Clark AF. Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma. Prog Retin Eye Res 1999;18:629-67.
43. Gobeil S, Rodrigue MA, Moisan S, et al. Intracellular sequestration of hetero-oligomers formed by wild-type and glaucoma-causing myocilin mutants. Invest Ophthalmol Vis Sci 2004;45:3560-7.
44. Wiggs JL, Vollrath D. Molecular and clinical evaluation of a patient hemizy-gous for TIGR/MYOC. Arch Ophthalmol 2001;119:1674-8.
45. Lam DS, Leung YF, Chua JK, et al. Truncations in the TIGR gene in individuals with and without primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2000; 41:1386-91.
46. Kim BS, Savinova OV, Reedy MV, et al. Targeted disruption of the myocilin gene (Myoc) suggests that human glaucomacausing mutations are gain of function. Mol Cell Biol 2001;21:7707-13.
47. Gould DB, Miceli-Libby L, Savinova OV, et al. Genetically increasing Myoc expression supports a necessary pathologic role of abnormal proteins in glaucoma. Mol Cell Biol 2004;24:9019-25.
48. Zhou Z, Vollrath D. A cellular assay distinguishes normal and mutant TIGR/ myocilin protein. Hum Mol Genet 1999;8: 2221-8.
49. Shepard AR, Jacobson N, Millar JC, et al. Glaucoma-causing myocilin mutants require the peroxisomal targeting signal-1 receptor (PTS1R) to elevate intraocular pressure. Hum Mol Genet 2007;16:609-17.
50. Senatorov V, Malyukova I, Fariss R, et al. Expression of mutated mouse myocilin induces open-angle glaucoma in transgenic mice. J Neurosci 2006;26:11903-14.
51. Alvarado J, Murphy C, JusterR. Trabecular meshwork cellularity in primary open-angle glaucoma and nonglaucomatous normals. Ophthalmology 1984;91:564-79.
52. Littjen-Drecoll E, Rohen JW. Morphology of aqueous outflow pathways in normal and glaucomatous eyes. In: Ritch R, Shields MB, Krupin T, eds. The glaucomas. 2nd ed. St. Louis: Mosby, 1996:89-123.
53. Rodrigues MM, Spaeth GL, Sivalingam E, Weinreb S. Histopathology of 150 trabeculectomy specimens in glaucoma. Trans Ophthalmol Soc U K 1976;96:245-55.
54. Wilkinson CH, van der Straaten D, Craig JE, et al. Tonography demonstrates reduced facility of outflow of aqueous humor in myocilin mutation carriers. J Glaucoma 2003;12:237-42.
55. Zhou Y, Grinchuk O, Tomarev SI. Transgenic mice expressing the Tyr437His mutant of human myocilin protein develop glaucoma. Invest Ophthalmol Vis Sci 2008;49:1932-9.
56. Paper W, Kroeber M, Heersink S, et al. Elevated amounts of myocilin in the aqueous humor of transgenic mice cause significant changes in ocular gene expression. Exp Eye Res 2008;87:257-67.
57. Minckler DS, McLean IW, Tso MO. Distribution of axonal and glial elements in the rhesus optic nerve head studied by electron microscopy. Am J Ophthalmol 1976;82:179-87.
58. Zhang J, Rubin RM, Rao NA. Anatomy and embryology of the optic nerve. In: Tasman W, Jaeger EA, eds. Duane's foundations of clinical ophthalmology. Philadelphia: Lippincott Williams 8c Wilkins, 2005:1-10.
59. Kuehn MH, Fingert JH, Kwon YH. Retinal ganglion cell death in glaucoma: mechanisms and neuroprotective strategies. Ophthalmol Clin North Am 2005;18: 383-95.
60. Vrabec JP, Levin LA. The neurobiology of cell death in glaucoma. Eye 2007;21: Suppl 1:S11-S14.
61. Wax MB, Tezel G. Neurobiology of glaucomatous optic neuropathy: diverse cellular events in neurodegeneration and neuroprotection. Mol Neurobiol 2002;26: 45-55.
62. Quigley HA, McKinnon SJ, Zack DJ, et al. Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest Ophthalmol Vis Sci 2000;41:3460-6.
63. Pease ME, McKinnon SJ, Quigley HA, Kerrigan-Baumrind LA, Zack DJ. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest Ophthalmol Vis Sci 2000;41:764-74.
64. Balaratnasingam C, Morgan WH, Bass L, Matich G, Cringle SJ, Yu DY. Axonal transport and cytoskeletal changes in the laminar regions after elevated intraocular pressure. Invest Ophthalmol Vis Sci 2007;48:3632-44.
65. Rajendram R, Rao NA. Neuroglobin in normal retina and retina from eyes with advanced glaucoma. Br J Ophthalmol 2007; 91:663-6.
66. Tezel G, Wax MB. Hypoxia-inducible factor lalpha in the glaucomatous retina and optic nerve head. Arch Ophthalmol 2004;122:1348-56.
67. Mozaffarieh M, Grieshaber MC, Flammer J. Oxygen and blood flow: players in the pathogenesis of glaucoma. Mol Vis 2008;14:224-33.
68. Ko ML, Peng PH, Ma MC, Ritch R, Chen CF. Dynamic changes in reactive oxygen species and antioxidant levels in retinas in experimental glaucoma. Free Radic Biol Med 2005;39:365-73.
69. Tezel G, Yang X, Cai J. Proteomic identification of oxidatively modified retinal proteins in a chronic pressure-induced rat model of glaucoma. Invest Ophthalmol Vis Sci 2005;46:3177-87.
70. Liu Q, Ju WK, Crowston JG, et al. Oxidative stress is an early event in hydrostatic pressure induced retinal ganglion cell damage. Invest Ophthalmol Vis Sci 2007;48:4580-9.
71. Moreno MC, Campanelli J, Sande P, Sanez DA, Keller Sarmiento MI, Rosen-stein RE. Retinal oxidative stress induced by high intraocular pressure. Free Radic Biol Med 2004;37:803-12.
72. Tezel G, Luo C, Yang X. Accelerated aging in glaucoma: immunohistochemical assessment of advanced glycation end products in the human retina and optic nerve head. Invest Ophthalmol Vis Sci 2007;48:1201-11.
73. Munemasa Y, Ahn JH, Kwong JM, Caprioli J, Piri N. Redox proteins thiore-doxin 1 and thioredoxin 2 support retinal ganglion cell survival in experimental glaucoma. Gene Ther 2009;16:17-25.
74. Yang Z, Quigley HA, Pease ME, et al. Changes in gene expression in experimental glaucoma and optic nerve transection: the equilibrium between protective and detrimental mechanisms. Invest Ophthalmol Vis Sci 2007;48:5539-48.
75. Ahmed F, Brown KM, Stephan DA, Morrison JC, Johnson EC, Tomarev SI. Mi-croarray analysis of changes in mRNA levels in the rat retina after experimental elevation of intraocular pressure. Invest Ophthalmol Vis Sci 2004;45:1247-58.
76. Kim CY, Kuehn MH, Clark AF, Kwon YH. Gene expression profile of the adult human retinal ganglion cell layer. Mol Vis 2006;12:1640-8.
77. Soto I, Oglesby E, Buckingham BP, et al. Retinal ganglion cells downregulate gene expression and lose their axons within the optic nerve head in a mouse glaucoma model. J Neurosci 2008;28:548-61.
78. Huang W, Fileta J, Guo Y, Grosskreutz CL. Downregulation of Thy l in retinal ganglion cells in experimental glaucoma. Curr Eye Res 2006;31:265-71.
79. Schlamp CL, Johnson EC, Li Y, Morrison JC, Nickells RW. Changes in Thyl gene expression associated with damaged retinal ganglion cells. Mol Vis 2001;7:192-201.
80. Steele MR, Inman DM, Calkins DJ, Horner PJ, Vetter ML. Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma. Invest Ophthalmol Vis Sci 2006;47:977-85.
81. Tezel G, Wax MB. The immune system and glaucoma. Curr Opin Ophthalmol 2004;15:80-4.
82. Pena JD, Varela HJ, Ricard CS, Hernandez MR. Enhanced tenascin expression associated with reactive astrocytes in human optic nerve heads with primary open angle glaucoma. Exp Eye Res 1999; 68:29-40.
83. Agapova OA, Ricard CS, Salvador-Silva M, Hernandez MR. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes. Glia 2001;33:205-16.
84. Hernandez MR, Agapova OA, Yang P, Salvador-Silva M, Ricard CS, Aoi S. Differential gene expression in astrocytes from human normal and glaucomatous optic nerve head analyzed by cDNA microarray. Glia 2002;38:45-64.
85. Yang P, Agapova O, Parker A, et al. DNA microarray analysis of gene expression in human optic nerve head astrocytes in response to hydrostatic pressure. Physiol Genomics 2004;17:157-69.
86. Hernandez MR The optic nerve head in glaucoma: role of astrocytes in tissue remodeling. Prog Retin Eye Res 2000;19: 297-321.
87. Burgoyne CF, Downs JC Premise and prediction: how optic nerve head biome-chanics underlies the susceptibility and clinical behavior of the aged optic nerve head. J Glaucoma 2008;17:318-28.
88. Nakazawa T, Nakazawa C, Matsubara A, et al. Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J Neurosci 2006;26:12633-41.
89. Kitaoka Y, Kwong JM, Ross-Cisneros FN, et al. TNF-alpha-induced optic nerve degeneration and nuclear factor-kappaB p65. Invest Ophthalmol Vis Sci 2006;47: 1448-57.
90. Tezei G, Li LY, Patil RV, Wax MB. TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci 2001:42:1787-94.
91. Yan X, Tezel G, Wax MB, Edward DP. Matrix metalloproteinases and tumor necrosis factor alpha in glaucomatous optic nerve head. Arch Ophthalmol 2000;118: 666-73.
92. Yang H, Downs JC, Bellezza A, Thompson H, Burgoyne CF. 3-D histomorphometry of the normal and early glaucomatous monkey optic nerve head: prelaminar neural tissues and cupping. Invest Ophthalmol Vis Sci 2007;48:5068-84.
93. Johnson EC,Jia L, Cepurna WO, Doser TA, Morrison JC. Global changes in optic nerve head gene expression after exposure to elevated intraocular pressure in a rat glaucoma model. Invest Ophthalmol Vis Sci 2007;48:3161-77.
94. Malone P, Miao H, Parker A, Juarez S, Hernandez MR. Pressure induces loss of gapjunction communication and redistri bution of connexin 43 in astrocytes. Glia 2007;55:1085-98.
95. Morrison JC, Dorman-Pease ME, Dun-kelberger GR, Quigley HA. Optic nerve head extracellular matrix in primary optic atrophy and experimental glaucoma. Arch Ophthalmol 1990;108:1020-4.
96. Quigley HA. Neuronal death in glaucoma. Prog Retin Eye Res 1999;18:39-57.
97. Howell GR, Libby RT, Jakobs TC, et al. Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. J Ceil Biol 2007;179:1523-37.
98. Schlamp CL, Li Y, Dietz JA, Janssen KT, Nickells RW. Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. BMC Neurosci 2006;7:66.
99. Jakobs TC, Libby RT, Ben Y, John SW, Masland RH. Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J Cell Biol 2005; 171:313-25.
100. Libby RT, Li Y, Savinova OV, et al. Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet 2005;1:17-26.
101. May CA, Lutjen-Drecoll E. Morphology of the murine optic nerve. Invest Ophthalmol Vis Sci 2002;43:2206-12.
102. Du J, Tran T, Fu C, Sretavan DW. Up-regulation of EphB2 and ephrin-B2 at the optic nerve head of DBA/2J glaucomatous mice coincides with axon loss. Invest Ophthalmol Vis Sci 2007;48:5567-81.
103. Pena JD, Agapova O, Gabelt BT, et al. Increased elastin expression in astrocytes of the lamina cribrosa in response to elevated intraocular pressure. Invest Ophthalmol Vis Sci 2001;42:2303-14.
104. Kerrigan LA, Zack Di, Quigley HA, Smith SD, Pease ME. TUNEL-positive ganglion cells in human primary open- angle glaucoma. Arch Ophthalmol 1997; 115:1031-5.
105. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 1995; 36:774-86.
106. Cordeiro MF, Guo L, Luong V. et al. Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration. Proc Nati Acad Sci U S A 2004;101: 13352-6.
107. Streit WJ, Mrak RE, Griffin WS. Microglia and neuroinflammation: a pathological perspective. J Neuroinflammation 2004;1:14.
108. Yang J, Yang P, Tezel G, Patil RV, Hernandez MR, Wax MB. Induction of HLA-DR expression in human lamina enbrosa astrocytes by cytokines and simulated ischemia. Invest Ophthalmol Vis Sci 2001;42:365-71.
109. Stasi K, Nagel D, YangX, et al. Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes. Invest Ophthalmol Vis Sci 2006:47:1024-9.
110. Kuehn MH, Kim CY, Ostojic J, et al. Retinal synthesis and deposition of complement components induced by ocular hypertension. Exp Eye Res 2006;83:620-8.